ArticleAlimentary pharmacology & therapeutics2022

Letter: loss of response to anti-TNFα agents in patients with inflammatory bowel disease depends on treatment duration.

Shomron Ben-Horin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.